Assertio Holdings | DEPO - Interest Expense On Debt


Assertio Holdings reported $758K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
ANI Pharmaceuticals USD 4.41M 316K Dec/2025
Assertio Holdings USD 758K 1000 Jun/2024
Aurora Cannabis CAD 2.11M 116K Dec/2025
Cara Therapeutics -89.64M 128.67M Dec/2025
Daiichi Sankyo JPY 2.16B 1.33B Dec/2025
Ironwood Pharmaceuticals USD 8.74M 506K Dec/2024
J&J USD 43M 25M Mar/2026
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Merck USD 479M 67M Mar/2026
Nektar Therapeutics USD 9.77M 3.75M Dec/2025
Omeros USD 4.05M 5.16M Sep/2024
Pfizer USD 671M 40M Mar/2026
Teva Pharmaceutical Industries USD 216M 4M Mar/2026